The White House Is Pushing Precision Medicine, but It Won’t Happen for Years
By Mike Orcutt,
MIT Technology Review
| 07. 18. 2016
With the right technologies to collect and make sense of biomedical information, we could speed up the pace of discoveries that lead to a new class of tailor-made drugs. That’s the argument behind the White House’s push for “precision medicine” (see “A Shot in the Arm for Obama’s Precision Medicine Initiative”).
The goal of precision medicine is to provide drugs and therapies that are uniquely suited to individual patients based on their genetics and other distinguishing health information. To a small degree, that already is happening. Dozens of targeted drugs have gotten approval from the U.S. Food and Drug Administration in recent years, and there are particularly successful examples in oncology. But despite the early successes, we are many years from realizing a “new era of medicine” the president described in his 2015 State of the Union address—if we can realize it at all.
Here are four reasons why:
Continue reading on MIT Technology Review
Image via Flickr/DoD News
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Émile P. Torres, Truthdig | 10.17.2025
The Internet philosopher Eliezer Yudkowsky has been predicting the end of the world for decades. In 1996, he confidently declared that the singularity — the moment at which computers become more “intelligent” than humanity — would happen in 2021, though...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Carter Sherman, The Guardian | 10.16.2025